\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\ \(415\)\
\-\ n\\/a\\ \ \(1\)\
\-\ lab\ \(1091\)\
\-\ hbv\\ e\\ ag\\ \\(\\-\\)\ \(0\)\
\-\ hbv\\ e\\ ab\\ \\(\\+\\)\ \(0\)\
\-\ ferritin\\ 760\\ \\(150\\)\ \(0\)\
\-\ afp\\ 2483\\ \\(15\\)\ \(0\)\
\-\ currently\\ not\\ determined\\.\ \(0\)\
\-\ ct\\ findings\ \(1\)\
\-\ increased\\ portal\\ venous\\ diameter\\ \\(\\>13mm\\)\ \(0\)\
\-\ portal\\ vein\\ thrombosis\ \(7\)\
\-\ ascites\\ \\(not\\ seen\\ on\\ these\\ images\\)\ \(0\)\
\-\ enlarged\\ splenic\\ and\\ mesenteric\\ veins\\ \\(\\>10mm\\,\\ 10mm\\ on\\ these\\ images\\)\ \(0\)\
\-\ porto\\-systemic\\ collaterals\ \(0\)\
\-\ hepatocellular\\ carcinoma\\ \\(hepatoma\\)\\ with\\ portal\\ vein\\ invasion\\ and\\ thrombosis\ \(0\)\
\-\ differential\\ for\\ portal\\ hypertension\ \(0\)\
\-\ prehepatic\ \(0\)\
\-\ \\ \\ portal\\/splenic\\ vein\\ occlusion\ \(0\)\
\-\ intraheptic\ \(0\)\
\-\ \\ \\ cirrhosis\ \(1\)\
\-\ \\ \\ metastatic\ \(0\)\
\-\ \\ \\ parasitic\ \(0\)\
\-\ posthepatic\ \(0\)\
\-\ \\ \\ cardiac\\ \\(chf\\,\\ tricuspid\\ insufficiency\\,\\ conststrictive\\ pericarditis\\)\ \(0\)\
\-\ \\ \\ hepatic\\ vein\\ occlusion\\ \\(budd\\-chiari\\)\ \(0\)\
\-\ 62\\ y\\/o\\ female\\ with\\ liver\\ mass\\ possibly\\ hemangioma\\ on\\ ct\\ scan\\ for\\ 3\\-phase\\ ct\\ scan\\ of\\ liver\\ to\\ evaluate\\.\\ pt\\ with\\ history\\ of\\ chronic\\ hepatitis\\ b\\ and\\ is\\ at\\ risk\\ for\\ hcc\\ \\(hepatocellular\\ carcinoma\\)\\.\ \(0\)\
\-\ originally\\ suspected\\ hemangioma\\ in\\ this\\ patient\\ with\\ known\\ hepatitis\\ b\\ infection\\ and\\ vague\\ history\\ of\\ findings\\ of\\ mass\\ discovered\\ in\\ ct\\ performed\\ at\\ another\\ institution\\.\\ \\ spect\\ imaging\\ with\\ tc99m\\-rbc\\ for\\ hemagioma\\ not\\ consistent\\ with\\ hemangioma\\.\\ \\ laboratory\\ findings\\ were\\ more\\ consistent\\ with\\ hcc\\ with\\ marked\\ elevation\\ of\\ alpha\\ feto\\-protein\\.\\ \\ follow\\-up\\ imaging\\ revealed\\ diffuse\\ involvement\\ of\\ the\\ liver\\ and\\ portal\\ vein\\ invasion\\/thrombosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ portal\\:\\ 0\\.10760838063230116\ \(0\)\
\-\ hbv\\:\\ 0\\.07772604060676126\ \(0\)\
\-\ vein\\:\\ 0\\.07396969669890233\ \(0\)\
\-\ 10mm\\:\\ 0\\.059104890855035785\ \(0\)\
\-\ hemangioma\\:\\ 0\\.05480822225170885\ \(0\)\
\-\ hcc\\:\\ 0\\.053947029604005284\ \(0\)\
\-\ e\\:\\ 0\\.04859185459983856\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.04711672847708968\ \(0\)\
\-\ hepatitis\\:\\ 0\\.046923401134338294\ \(0\)\
\-\ liver\\:\\ 0\\.04229026092104388\ \(0\)\
\-\ 760\\:\\ 0\\.042179513990270326\ \(0\)\
\-\ 2483\\:\\ 0\\.042179513990270326\ \(0\)\
\-\ porto\\-systemic\\:\\ 0\\.042179513990270326\ \(0\)\
\-\ portal\\/splenic\\:\\ 0\\.042179513990270326\ \(0\)\
\-\ intraheptic\\:\\ 0\\.042179513990270326\ \(0\)\
\-\ conststrictive\\:\\ 0\\.042179513990270326\ \(0\)\
\-\ tc99m\\-rbc\\:\\ 0\\.042179513990270326\ \(0\)\
\-\ feto\\-protein\\:\\ 0\\.042179513990270326\ \(0\)\
\-\ invasion\\/thrombosis\\:\\ 0\\.042179513990270326\ \(0\)\
\-\ occlusion\\:\\ 0\\.04078125868292782\ \(0\)\
\-\ prehepatic\\:\\ 0\\.03886302030338063\ \(0\)\
\-\ posthepatic\\:\\ 0\\.03886302030338063\ \(0\)\
\-\ hemagioma\\:\\ 0\\.03886302030338063\ \(0\)\
\-\ b\\:\\ 0\\.0385457098677938\ \(0\)\
\-\ \\(\\:\\ 0\\.03801903822336108\ \(0\)\
\-\ \\)\\:\\ 0\\.037554615374384474\ \(0\)\
\-\ thrombosis\\:\\ 0\\.0351007076282588\ \(0\)\
\-\ 3\\-phase\\:\\ 0\\.03447885412216458\ \(0\)\
\-\ ferritin\\:\\ 0\\.03286893911440758\ \(0\)\
\-\ 13mm\\:\\ 0\\.03286893911440758\ \(0\)\
\-\ hepatoma\\:\\ 0\\.03286893911440758\ \(0\)\
\-\ budd\\-chiari\\:\\ 0\\.03116236043527489\ \(0\)\
\-\ ag\\:\\ 0\\.029552445427517893\ \(0\)\
\-\ tricuspid\\:\\ 0\\.029552445427517893\ \(0\)\
\-\ 150\\:\\ 0\\.02891353924271156\ \(0\)\
\-\ collaterals\\:\\ 0\\.02862346928186738\ \(0\)\
\-\ pericarditis\\:\\ 0\\.028349984048183414\ \(0\)\
\-\ ab\\:\\ 0\\.02761242098680897\ \(0\)\
\-\ alpha\\:\\ 0\\.027389837179943456\ \(0\)\
\-\ spect\\:\\ 0\\.027177149320752863\ \(0\)\
\-\ \\>\\:\\ 0\\.02716906712601497\ \(0\)\
\-\ findings\\:\\ 0\\.02610770721229607\ \(0\)\
\-\ chf\\:\\ 0\\.02559704555582187\ \(0\)\
\-\ parasitic\\:\\ 0\\.025306975594977688\ \(0\)\
\-\ afp\\:\\ 0\\.02516827924630184\ \(0\)\
\-\ cirrhosis\\:\\ 0\\.024073343493053765\ \(0\)\
\-\ ascites\\:\\ 0\\.023461700567169147\ \(0\)\
\-\ carcinoma\\:\\ 0\\.02317634133986475\ \(0\)\
\-\ originally\\:\\ 0\\.023093465920584803\ \(0\)\
\-\ scan\\:\\ 0\\.022892549860602664\ \(0\)\
\-\ ct\\:\\ 0\\.022876624945302255\ \(0\)\
\-\ 62\\:\\ 0\\.022355902859210363\ \(0\)\
\-\ institution\\:\\ 0\\.022280551868932182\ \(0\)\
\-\ splenic\\:\\ 0\\.022133319052344842\ \(0\)\
\-\ vague\\:\\ 0\\.021990481908087996\ \(0\)\
\-\ insufficiency\\:\\ 0\\.02171699667440403\ \(0\)\
\-\ determined\\:\\ 0\\.021334017211851228\ \(0\)\
\-\ these\\:\\ 0\\.02128081044935732\ \(0\)\
\-\ \\+\\:\\ 0\\.021094732902881556\ \(0\)\
\-\ possibly\\:\\ 0\\.020922809413761633\ \(0\)\
\-\ elevation\\:\\ 0\\.020193294611635926\ \(0\)\
\-\ discovered\\:\\ 0\\.020145206880279456\ \(0\)\
\-\ consistent\\:\\ 0\\.0200507011371407\ \(0\)\
\-\ lab\\:\\ 0\\.020003777204482594\ \(0\)\
\-\ invasion\\:\\ 0\\.01968917731183771\ \(0\)\
\-\ veins\\:\\ 0\\.019560433517962474\ \(0\)\
\-\ imaging\\:\\ 0\\.019158601190962705\ \(0\)\
\-\ mesenteric\\:\\ 0\\.018853211008446634\ \(0\)\
\-\ not\\:\\ 0\\.01772466992931008\ \(0\)\
\-\ suspected\\:\\ 0\\.017606315726871942\ \(0\)\
\-\ another\\:\\ 0\\.01757825295437243\ \(0\)\
\-\ diameter\\:\\ 0\\.017201734922909922\ \(0\)\
\-\ hepatic\\:\\ 0\\.01707413565457422\ \(0\)\
\-\ evaluate\\:\\ 0\\.016527398364866375\ \(0\)\
\-\ 15\\:\\ 0\\.016307878720126217\ \(0\)\
\-\ currently\\:\\ 0\\.016201783708191662\ \(0\)\
\-\ hypertension\\:\\ 0\\.016118569628230564\ \(0\)\
\-\ marked\\:\\ 0\\.01595636124700721\ \(0\)\
\-\ images\\:\\ 0\\.01568673580812779\ \(0\)\
\-\ cardiac\\:\\ 0\\.015573381784454403\ \(0\)\
\-\ pt\\:\\ 0\\.01520174045278829\ \(0\)\
\-\ laboratory\\:\\ 0\\.01506742457346443\ \(0\)\
\-\ involvement\\:\\ 0\\.014985352424056537\ \(0\)\
\-\ venous\\:\\ 0\\.014841079514148942\ \(0\)\
\-\ n\\/a\\:\\ 0\\.014809601183536298\ \(0\)\
\-\ risk\\:\\ 0\\.014809601183536298\ \(0\)\
\-\ for\\:\\ 0\\.013954222940530432\ \(0\)\
\-\ enlarged\\:\\ 0\\.013950340049684241\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.013301612399242784\ \(0\)\
\-\ revealed\\:\\ 0\\.013121884640507623\ \(0\)\
\-\ differential\\:\\ 0\\.01298066903996617\ \(0\)\
\-\ known\\:\\ 0\\.012938043466334065\ \(0\)\
\-\ diffuse\\:\\ 0\\.012378025934810119\ \(0\)\
\-\ infection\\:\\ 0\\.011885246765898598\ \(0\)\
\-\ chronic\\:\\ 0\\.011516696808167463\ \(0\)\
\-\ performed\\:\\ 0\\.011399896321661813\ \(0\)\
\-\ mass\\:\\ 0\\.011372832602369038\ \(0\)\
\-\ y\\/o\\:\\ 0\\.011323583874735123\ \(0\)\
\-\ history\\:\\ 0\\.011293919021120416\ \(0\)\
\-\ at\\:\\ 0\\.011079073232838592\ \(0\)\
\-\ on\\:\\ 0\\.010390780081800404\ \(0\)\
\-\ metastatic\\:\\ 0\\.010292389490986077\ \(0\)\
\-\ more\\:\\ 0\\.010225723968000795\ \(0\)\
\-\ physical\\:\\ 0\\.01003112569177626\ \(0\)\
\-\ increased\\:\\ 0\\.010002319530141893\ \(0\)\
\-\ were\\:\\ 0\\.009283666682726895\ \(0\)\
\-\ exam\\:\\ 0\\.008981980573921234\ \(0\)\
\-\ \\-\\:\\ 0\\.00876425099860461\ \(0\)\
\-\ female\\:\\ 0\\.008405551538027911\ \(0\)\
\-\ seen\\:\\ 0\\.008079557966831054\ \(0\)\
\-\ this\\:\\ 0\\.004598742647436043\ \(0\)\
\-\ with\\:\\ 0\\.004478628749852239\ \(0\)\
\-\ and\\:\\ 0\\.004306435543832978\ \(0\)\
\-\ patient\\:\\ 0\\.004098525985245875\ \(0\)\
\-\ in\\:\\ 0\\.004032509379332583\ \(0\)\
\-\ \\,\\:\\ 0\\.0038857904141237423\ \(0\)\
\-\ of\\:\\ 0\\.003344606721473352\ \(0\)\
\-\ is\\:\\ 0\\.0026903864994484478\ \(0\)\
\-\ to\\:\\ 0\\.0020433880786745752\ \(0\)\
\-\ \\.\\:\\ 0\\.00118897967790155\ \(0\)\
\-\ the\\:\\ 0\\.0006614798311178268\ \(0\)\
